Taken together, because the specific outcomes of HDAC inhibition are similar with that imposed by DMY, to further examine whether DMY interfere with the HDAC function and whether the acetylation pattern of p53 was modulated by DMY in leukemia and myocardial cells may be beneficial to fully understanding the dual modes of action by DMY. Here, TP53 is linked to leukemia.